Spencer R. Berthelsen, Director at IONIS PHARMACEUTICALS INC (IONS), sold 15,000 shares at $42.47 ($635K) on 2018-06-25, disclosed to the SEC on 2018-06-25.
Open-market sale of $635k IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.03 | 5,700 | $240K | 37.8% |
| 2 | $42.47 | 9,300 | $395K | 62.2% |
| Total | $42.30 avg | 15,000 | $635K | 100% |
| Filing → |
| IONS | SELL | 2024-06-20 | $645K | — | Filing → |
| IONS | SELL | 2021-06-25 | $566K | — | Filing → |
| IONS | SELL | 2020-06-25 | $881K | — | Filing → |